MANCHESTER, N.H., Dec. 4, 2013 /PRNewswire/ -- Lyophilization Services of New England (LSNE), a New Hampshire based contract manufacturing organization is pleased to announce that Shawn Cain has been named, Chief Operating Officer, a new position within the company. Mr. Cain joined LSNE in 2012 as Vice President of Sterile Manufacturing. In his new role, Cain will be leading operations, quality, regulatory, and will drive the overall strategic growth of LSNE. Shawn will be responsible for overseeing day-to-day operations and ensuring companywide alignment with the corporate goals. Mr. Cain will report to Matthew Halvorsen, President and Chief Executive Officer of LSNE.
"Shawn brings over 25 years of industry experience to the position and he has proven to be a trusted leader with a strong track record of manufacturing success. I have tremendous confidence in his ability to lead the company with a focus on customer experience coupled with regulatory compliance. This new appointment underlines LSNE's commitment to continuous improvement and risk management in an era of changing regulation," said Matthew Halvorsen.
Commenting on his recent promotion, Mr. Cain said, "LSNE has a strong foundation and I look forward to continuing the strong growth of the company. I am exciting to be working with such a talented and dedicated team."
Mr. Cain's 28 year career includes extensive experience in the pharmaceutical, biotech and medical device industries. Shawn has held key management positions within operations at Organogenesis, Inc, Formatech Inc., Arbios Systems, Inc. and Becton Dickinson. Mr. Cain received his M.S. degree in Biological Sciences from the University of Massachusetts and a B.S. in Biological Sciences from Northeastern University.
About LSNE Contract Manufacturing
LSNE Contract Manufacturing is a privately held company with three GMP facilities located in New England. LSNE has been providing contract lyophilization services to the pharmaceutical, biotechnology and medical device industries since 1997, specializing in a wide range of services including cycle development, cGMP fill/finish, and lyophilization. Through the thoughtful integration of three processing facilities, qualified staffing, and an extensive manufacturing history, LSNE is strategically positioned to provide uninterrupted manufacturing for clinical through commercial supply for medical device and pharmaceuticals to a multi-national market.
|SOURCE Lyophilization Services of New England|
Copyright©2012 PR Newswire.
All rights reserved